Compound Detail
CHEMBL2107554
SODIUM DIBUNATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL2107554 |
| Name | SODIUM DIBUNATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | XYEXKDCAGSHWSD-UHFFFAOYSA-M |
| Parent Compound | CHEMBL1865134 |
| Active Moiety | CHEMBL1865134 |
1
Targets
3
Activities
1
Assay Types
0
PK Parameters
1
Publications
13
Known Names
Molecular Properties
320.4
MW (Da)
4.68
ALogP
2
HBA
1
HBD
54.4
PSA (Ų)
0.78
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Withdrawn |
| Chirality | Achiral |
Drug Warnings
Withdrawn
neurotoxicity
central nervous system toxicity in experimental mice. Prolonged administration in humans results in reduction in granular leukocytes
Withdrawn
hematological toxicity
central nervous system toxicity in experimental mice. Prolonged administration in humans results in reduction in granular leukocytes
Activity Summary
EC50 3 meas. best 5.2
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nuclear receptor subfamily 1 group I member 2 CHEMBL3401 | EC50 | 5.2 | 4.95 | 6300.0 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Nuclear receptor subfamily 1 group I member 2 | EC50 | = | 6300.0 | nM | 5.2 | Competitive binding affinity to human PXR LBD (111 to 434) by TR-FRET assay | 20966043 |
| Nuclear receptor subfamily 1 group I member 2 | EC50 | = | 8900.0 | nM | 5.05 | Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induc... | 20966043 |
| Nuclear receptor subfamily 1 group I member 2 | EC50 | = | 25100.0 | nM | 4.6 | Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by l... | 20966043 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20966043 | 10.1124/dmd.110.035105 | Nuclear receptor subfamily 1 group I member 2 | 7 |
Data from ChEMBL 36 via Core Engine